Pharma Journalist -

Tubulis, a German biotech company specializing in next-generation antibody-drug conjugates (ADCs), has secured €308 million (USD 361 million) in a major Series C financing round aimed…
Read More...

Novo Nordisk and Omeros Corporation have entered into a definitive agreement granting Novo Nordisk exclusive global rights to zaltenibart (formerly OMS906), a clinical-stage antibody…
Read More...

Adcytherix SAS, a French biopharmaceutical company developing next-generation antibody drug conjugates (ADCs), has closed a €105 million (US$122 million) Series A funding round — the…
Read More...

Minovia Therapeutics Ltd., a clinical-stage biotech company focused on mitochondrial disease therapies, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan…
Read More...

Viatris Inc., a global healthcare company, has announced the acquisition of Aculys Pharma, Inc., a clinical-stage biopharmaceutical firm focused on innovative neurological treatments.…
Read More...

Avantor, Inc., a global leader in life sciences and advanced technology products, has announced a strategic partnership with BlueWhale Bio, a commercial-stage company focused on…
Read More...

Johnson & Johnson has announced plans to separate its Orthopaedics division into a standalone company, DePuy Synthes, as part of a strategic move to sharpen its focus on high-growth…
Read More...

BioCryst Pharmaceuticals announced it will acquire Astria Therapeutics in a cash-and-stock deal valued at approximately $700 million, aiming to expand its portfolio of treatments for…
Read More...

Nabla Bio, a biotechnology company using generative AI to design novel therapeutics, announced a major expansion of its partnership with global pharmaceutical company Takeda. The new…
Read More...

Pfizer Inc. announced positive topline results from its Phase 3 HER2CLIMB-05 trial, marking a potential breakthrough in first-line treatment for patients with HER2-positive (HER2+)…
Read More...